Utility of PET in unknown primary with cervical metastasis: A retrospective study

Indian Journal of Cancer

Volumn 48, Issue 2, 2011, Pages 181-186

  Dandekar, M R ^a   Kannan, S ^a   Rangarajan, V ^a   Purandare, N C ^a   Chaukar, D A ^a   Deshmukh, A ^a   D'Cruz, A K ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Cervical neoplasm; PET scan; unknown primary neoplasm

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER OF UNKNOWN PRIMARY SITE; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DISTANT METASTASIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; HEAD AND NECK TUMOR; MEDICAL RECORD; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SCINTISCANNING; UTILIZATION REVIEW;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDICAL RECORDS; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84855733061     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.82882     Document Type: Article

References (28)

1. Talmi YP, Wolf GT, Hazuka M, Krause CJ. Unknown primary of the head and neck. J Laryngol Otol 1996;110:353-6.
2. Iganej S, Kagan R, Anderson P, Rao A, Tome M, Wang R et al. Metastatic squamous cell carcinoma of the neck from an unknown primary: Management options and patterns of relapse. Head Neck 2002;24:236-46.
3. Kwee TC, Basu S, Cheng G. FDG PET/CT in carcinoma of unknown primary. Eur J Nucl Med Mol Imaging 2010;37:635-44
4. The NCCN Clinical Practice Guidelines in Oncology. Head and Neck Cancers: Version 1. 2010. p. 61-7. Available from: Http://www. nccn.org/professionals/ physician-gls/PDF/head-and-neck.pdf. [cited in 2010]
5. Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, et al. Utility of combined (18) F- fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumours. Oral Oncol 2009;45:218-24.
6. Aassar OS, Fischbein NJ, Caputo GR, Kaplan MJ, Price DC, Singer MI, et al. Metastatic head and neck cancer: Role and usefulness of FDG PET in locating occult primary tumors. Radiology 1999;210:177-81.
7. Menda Y, Graham MM. Update on 18F-Fluorodeoxyglucose/ Positron Emission Tomography and positron emission tomography/ computed tomography imaging of squamous head and neck cancers. Semin Nucl Med 2005;35:214-9.
8. Wartski M, Le Stanc E, Gontier E, Vilain D, Banal A, Tainturier C, et al. In search of an unknown primary tumour presenting with cervical metastases: Performance of hybrid FDG-PET-CT. Nucl Med Commun 2007;28:365-71.
9. Miller FR, Hussey D, Beeram M, Eng T, McGuff HS, Otto RA. Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg 2005;131:626-9.
10. Gutzelt A, Antoch G, Kuhl H, Egelhof T, Flscher M, Hauth E, et al. Unknown primary tumours: Detection with dual modality PET/CT: Initial experience. Radiology 2005;234:227-34.
11. Nassenstein S, Veit-Haibach P, Stergar H, Gutzeit A, Freudenberg L, Kuehl H, et al. Cervical lymph node metastases of unknown origin: Primary tumour detection with whole-body positron emission tomography/ computed tomography. Acta Radiol 2007;48:1101-8. 12. Padovani D, Aimoni C, Zucchetta P, Paluzzi A, Pastore A. 18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma. Eur Arch Otorhinolaryngol 2009;266:267-71.
12. Waltonen JD, Ozer E, Hall NC, Schuller DE, Agrawal A. Metastatic carcinoma of the neck of unknown primary origin. Arch Otolaryngol Head Neck Surg 2009;135:1024-9.
13. Cianchetti M, Mancuso AA, Amdur RJ, Werning JW, Kirwan J, Morris CG et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope 2009;119:2348-54.
14. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 7th ed. Heidelberg Springer; 2010. p. 21-8.
15. Pavlidis N, Fizazi K. Carcinoma of unknown primary (CUP). Crit Rev Oncol Hematol 2009;69:271-8.
16. Miller FR, Hussey D, Beeram M, Eng T, McGuff HS, Otto RA. Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg 2005;131:626-9.
17. Dong MJ, Zhao K, Lin XT, Zhao J, Ruan LX. Role of fluorodeoxyglucose - PET versus fluorodeoxyglucose- PET / computed tomography in detection of unknown primary tumour: A meta-analysis of literature. Nucl Med Commun 2008;29:791-802.
18. Kwee TC, Kwee RM. Combined FDG-PET/CT for the detection of unknown primary tumors: Systematic review and meta-analysis. Eur Radiol 2009;19:731-44.
19. Mistry RC, Qureshi SS, Talole SD, Deshmukh S. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary: Outcomes and patterns of failure. Indian J Cancer 2008;45:54-8.
20. Shenoy AM, Hasan S, Nayak U, Anantha N, Reddy BK, Kannan V, et al. Neck metastasis from an occult primary: The Kidwai experience. Indian J Cancer 1992;29:203-9.
21. Johansen J, Buus S, Loft A, Keiding S, Overgaard M, Hansen HS, et al. Prospective Study of 18 FDG- PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumour: Results from the DAHANCA-13 study. Head Neck 2008;30:471-8.
22. Pavlidis N, Fizazi K. Carcinoma of unknown primary (CUP). Crit Rev Oncol Hematol 2009;69:271-8.
23. Liao CT, Wang HM, Chang JT, Ng SH, Hsueh C, Lee LY, et al. Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer 2007;110:1501-8.
24. Lim YC, Koo BS, Choi EC. Bilateral neck node metastasis: A predictor of isolated distant metastasis in patients with Oral and Oropharyngeal squamous cell carcinoma after primary curative surgery. Laryngoscope 2007;117:1576-80.
25. Matsuo JM, Patel SG, Singh B, Wong RJ, Boyle JO, Kraus DH, et al. Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx. Ann Surg 2003;238:412-22.
26. Machtay M, Natwa M, Andrel J, Hyslop T, Anne PR, Lavarino J, et al. Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck 2009;31:195-201.
27. Wong WL, Saunders M. The impact of FDG PET on the management of occult primary head and neck tumours. Clin Oncol (R Coll Radiol) 2003;15:461-6.
28. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003;39:1990-2005.